Navigation Links
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
Date:4/25/2008

f Executive Officer of Isis. "Conducting an outcome study in parallel with our continued evaluation of the effects of mipomersen on atherogenic lipids will allow us to submit a much stronger NDA for high risk patients. We are confident that mipomersen will bring benefit to patients with high cholesterol and remain committed to its development and commercialization."

"We are pleased that the FDA has given clear direction on what will be required for the approval of mipomersen, and has acknowledged its potential to help high risk patients whose needs are not being met by current therapies," said Henri A. Termeer, Genzyme's chairman and chief executive officer. "Having outcome data earlier on in the development process will be important to patients and serve to enhance the value of this treatment. We plan to engage in discussions with regulatory agencies in Europe and the rest of the world, and look forward to receiving their feedback."

ABOUT MIPOMERSEN

In early 2008, Isis and Genzyme announced that they had entered into a strategic alliance in which Genzyme will develop and commercialize mipomersen. Final contracts are still being negotiated and are expected to be completed this quarter.

Mipomersen is a second-generation antisense drug that reduces the production of apoB-100, a protein critical to the synthesis and transport of "bad" cholesterol. Cholesterol can be carried in the bloodstream in a variety of forms, with high-density lipoprotein, or HDL-cholesterol, being the good form, and low-density lipoproteins, or LDL-cholesterol, and very low-density lipoproteins, or VLDL-cholesterol, being bad forms directly involved in heart disease. Collectively lowering LDL-cholesterol, VLDL-cholesterol, and other bad forms of cholesterol are a key component in the prevention and management of cardiovascular disease.

Mipomersen is currently in phase 3 development for patients with homozygous familial hypercholesterolemia, a disease which crea
'/>"/>

SOURCE Genzyme Corp. and Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Kathleen Doheny HealthDay ... A simple urine test can routinely spot human papillomavirus (HPV), ... new analysis found. "Our study shows that testing urine ... taken from the cervix for HPV," said lead researcher Dr. ... and research fellow at Queen Mary University of London, England. ...
(Date:9/16/2014)... MN (PRWEB) September 16, 2014 Cliff Lake ... their team. Kristaleen is the newest dental hygienist to join ... looks forward to working with her and knows she will ... her patients. , Kristaleen grew up in River Falls, WI. ... County Technical College in 2003 and practiced dental assisting in ...
(Date:9/16/2014)... CO (PRWEB) September 16, 2014 Aspen ... that it has been recognized for its high morale ... Consulting magazine “The Best Small Firms to Work For ... survey annually, with more than 10,000 consultants participating across ... Extensive employee satisfaction surveys were conducted, and firms were ...
(Date:9/16/2014)... Treatment with endocrine therapy and radiation therapy as ... of care for women with hormone-receptor positive (HR+) ... at Fox Chase Cancer Center, however, shows that ... populations with the disease. , The results, ... Society for Radiation Oncology,s 56th Annual Meeting on ...
(Date:9/16/2014)... York, NY (PRWEB) September 16, 2014 ... children around the world will be honored in New ... Award ( http://www.worldofchildren.org ), the only global recognition and ... , Hailed by the media as the “Nobel ... individuals have each created life-changing programs that benefit children ...
Breaking Medicine News(10 mins):Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8
... inventor,of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion ... at the Piper,Jaffray 19th Annual Healthcare Conference at The ... 2007 at 8:30 a.m. ET. Joe Kiani, Chairman and,CEO, ... will be,presenting. A live Web cast of the ...
... to 60%, study found , THURSDAY, Nov. 15 (HealthDay News) ... oils, fruits and vegetables may reduce the risk of dementia ... may boost the risk of developing memory problems, say French ... people older than 65 who did not have dementia at ...
... a 150 percent increase between 1998 and 2003 in ... cancer has been found in only one breasta procedure ... study to examine these trends on a national level. ... unnecessary since most patients will never develop cancer in ...
... Just and Stanford postdoctoral fellow Sashank Varma have put ... provides answers to one of the central questions of ... to give rise to complex cognitive tasks such as ... theory, called 4CAPS, is described in the fall issue ...
... Proceeds from the Mural will Benefit St. Jude Children,s Research ... Jude Thanks and Giving Campaign, Event to be ... at Bryant Park, NEW YORK, Nov. 15 Visitors ... become artists for a day, as they,help put the finishing ...
... ... Affordable Program Company Provides Upscale ... the leading meal,delivery service provider based on the Dr. Sears, Zone Diet ... that provides,chef-prepared, gourmet frozen meals for as low as $9.99 per day*. ...
Cached Medicine News:Health News:Masimo to Present at Piper Jaffray 19th Annual Healthcare Conference 2Health News:Fish, Fruits, Veggies May Cut Dementia Risk 2Health News:More women are choosing double mastectomy even when breast cancer is confined to a single breast 2Health News:Carnegie Mellon neuroscientist proposes new theory of brain flexibility 2Health News:Carnegie Mellon neuroscientist proposes new theory of brain flexibility 3Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 2Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 3Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 4Health News:CHEFS DIET(R) Introduces My Solution 2
(Date:9/16/2014)... , Sept. 16, 2014 ... of the "Global Laparoscopy Devices Industry Report ... The Global Laparoscopy Devices Industry Report 2014 ... current state of the global laparoscopic devices. ... the industry including definitions, classifications, applications and industry ...
(Date:9/16/2014)... 16, 2014 The National Association of ... simultaneously released the NAMCP Medical Technologies Dossier Template ... Template © , which provide medical directors and ... medical devices or diagnostics that accounts for evidence-based ... these technology types (instead of having to attempt ...
(Date:9/16/2014)... ORLANDO, Fla. , Sept. 16, 2014   ... standard in the patient experience at hospitals. The myComfort™ ... , Vestagen,s active barrier fabric that is fluid repellant, ... shown to inhibit the growth of bacteria on the ... the role clothing plays in the chain of transmission. ...
Breaking Medicine Technology:Global Laparoscopy Devices Industry Report 2014 2NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2
... Med, the leading platform for automated revenue and charge ... the App Store for iPhone, iPod touch and iPad. ... company,s presence at the Hospital Information and Management Systems ... users to access the charge and data capture platform ...
... NexBio, Inc. announced the presentation of "Treatment of Parainfluenza ... Stem Cell Transplantation" at the American Society for Blood ... Honolulu, Hawaii.  The data was presented by Dr. Yi-Bin Chen, ... Medical School. Parainfluenza virus (PIV) infection causes ...
Cached Medicine Technology:HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2NexBio’s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 2NexBio’s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: